NAFDAC Warns of Counterfeit Combiart Tablets in Circulation

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a warning about the circulation of counterfeit Combiart (Artemether Lumefantrine 20/120mg) Dispersible Tablets in Nigeria.

In Public Alert No. 043/2024, published on its website, NAFDAC revealed that the counterfeit drug bears manufacturing dates of February 2023 and June 2023, with expiry dates of May 2026 and June 2026. The product is falsely labeled with batch number 7225119 and NAFDAC Registration No. A11-0299, purportedly manufactured by Strides Arcolab Limited, Bangalore, India.

NAFDAC has directed its zonal directors and state coordinators to intensify surveillance efforts to identify and remove the counterfeit drug from circulation.

The agency has urged importers, distributors, retailers, and healthcare providers to remain vigilant and avoid trading in the counterfeit product. Consumers are advised to only purchase medical products from authorized suppliers and verify their authenticity.